Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 89

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 89
---
 contamination or injury from these materials.
In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages,
and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.

Although we maintain workers’
compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous
materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental
liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or
radioactive materials.

We may be affected by regulatory responses to climate-related issues.

The Biden administration
has made climate change and the limitation of greenhouse gas (“GHG”) emissions one of its primary objectives. Several states
and other geographic regions in the United States have also adopted legislation and regulations to reduce emissions of GHGs.

On March 6, 2024, the SEC
finalized new rules for public companies that will require extensive climate-related disclosures and significant analysis of the impact
of climate-related issues on our business strategy, results of operations, and financial condition (the “SEC Climate Disclosure
Rules”), the effectiveness of which has been delayed indefinitely pending court challenges. If implemented, the new rules would
require us to disclose our material climate-related risks and opportunities, GHG emissions inventory, climate-related targets and goals,
and financial impacts of physical and transition risks. As a result of the SEC Climate Disclosure Rules, our legal, accounting, and other
compliance expenses may increase significantly, and compliance efforts may divert management time and attention. We may also be exposed
to legal or regulatory action or claims as a result of these new regulations. All of these risks could have a material adverse effect
on our business, financial position, and/or stock price.

Risks Related to Intellectual Property

Our intellectual property rights are valuable, and any inability to protect them could reduce the value of our products, services and brand.

The loss of any procured
intellectual property rights in our products could permit our competitors to manufacture their own version of our products. We have attempted
to protect our intellectual property rights in our products through a combination of patents, confidentiality agreements, non-compete
agreements and other contractual protection mechanisms, and we will continue to do so. While we intend to defend against threats to our
intellectual property, our patents or various contractual protections may not adequately protect